YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Aspen Pharmacare (APNHY) one of those stocks right now? Let's take a closer look at the stock's year-…
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Aspen Pharmacare (APNHY) one of those stocks right now? A quick glance at the company's year-to-date…
This article first appeared on GuruFocus. Revenue: Group revenue was flat in constant exchange rate (CER) for FY2026. Commercial Pharma Revenue: Grew 5% in CER, or 7% excluding China discontinuations. Manufacturing Revenue: Declined 10% in…
New generic equivalent of Ozempic® expected to help expand access to semaglutide treatment options for adults with type 2 diabetes in Canada OAKVILLE, ON, July 21, 2026 /CNW/ -- Aspen Pharmacare Canada Inc., a subsidiary of Aspen Pharmacar…
From what we can see, insiders were net buyers in Aspen Pharmacare Holdings Limited's (JSE:APN ) during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it. Although we don't think shareholders sho…
This article first appeared on GuruFocus. People familiar with the matter say several major private credit managers are expected to provide the A$1.4 billion loan backing BGH Capital Pty.'s acquisition of Aspen Pharmacare Holdings Ltd.'s A…
This article first appeared on GuruFocus. Aspen Pharmacare Holdings Ltd. (APNHY) delivered its strongest rally in a quarter-century after the company said it plans to sell its Asia-Pacific assets excluding China for 26.5 billion rand, or a…
Investors can approximate the average market return by buying an index fund. When you buy individual stocks, you can make higher profits, but you also face the risk of under-performance. That downside risk was realized by Aspen Pharmacare…
Looking at Aspen Pharmacare Holdings Limited's (JSE:APN ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold. While inside…
Aspen Pharmacare Holdings (JSE:APN) Full Year 2025 Results Key Financial Results Revenue: R43.4b (down 3.0% from FY 2024). Net loss: R1.08b (down by 125% from R4.40b profit in FY 2024). R2.44 loss per share (down from R9.91 profit in FY 20…
Revenue Growth: 9% increase in constant currency, 4% in reported currency. Normalized EBITDA: Up 21% in constant exchange rate (CER), 12% in reported currency. Gross Margin: Growth above 20%. Normalized Headline Earnings Per Share: Increas…
When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares in a high quality company at the right price, you can gain well over 100%. For example, the Aspen Pharmacare Holdings Lim…
Key Insights Significantly high institutional ownership implies Aspen Pharmacare Holdings' stock price is sensitive to their trading actions A total of 7 investors have a majority stake in the company with 53% ownership 17% of Aspen Pharma…
Key Insights Aspen Pharmacare Holdings' Annual General Meeting to take place on 7th of December Salary of R9.17m is part of CEO Stephen Saad's total remuneration The overall pay is 148% above the industry average Over the past three years,…
With its stock down 11% over the past three months, it is easy to disregard Aspen Pharmacare Holdings (JSE:APN). However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price…
One simple way to benefit from the stock market is to buy an index fund. But if you choose individual stocks with prowess, you can make superior returns. For example, Aspen Pharmacare Holdings Limited (JSE:APN) shareholders have seen the s…
CAPE TOWN, South Africa (AP) — Danish pharmaceutical company Novo Nordisk signed a deal with South Africa's Aspen Pharmacare to produce human insulin for diabetes patients in Africa, where there is a dire need for the life-saving treatment…
Key Insights Given the large stake in the stock by institutions, Aspen Pharmacare Holdings' stock price might be vulnerable to their trading decisions A total of 7 investors have a majority stake in the company with 53% ownership 16% of As…
Most readers would already be aware that Aspen Pharmacare Holdings' (JSE:APN) stock increased significantly by 19% over the past three months. As most would know, fundamentals are what usually guide market price movements over the long-ter…
One simple way to benefit from the stock market is to buy an index fund. But many of us dare to dream of bigger returns, and build a portfolio ourselves. Just take a look at Aspen Pharmacare Holdings Limited (JSE:APN), which is up 58%, ove…
Every investor in Aspen Pharmacare Holdings Limited (JSE:APN) should be aware of the most powerful shareholder groups. With 68% stake, institutions possess the maximum shares in the company. In other words, the group stands to gain the mos…
(Adds details, background CEPI quote) By Natalie Grover and Nellie Peyton JOHANNESBURG, Jan 19 (Reuters) - The Coalition for Epidemic Preparedness (CEPI) will invest up to $50 million over 10 years to help Senegal's Institut Pasteur expand…
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in Aspen Pharmacare Holdings Limited's (JSE:APN) case, it's fantastic news for shareholders. While we would never sugg…
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. Sometimes these stories can cloud the minds of i…
It is hard to get excited after looking at Aspen Pharmacare Holdings' (JSE:APN) recent performance, when its stock has declined 12% over the past month. It is possible that the markets have ignored the company's differing financials and de…
Performance at Aspen Pharmacare Holdings Limited (JSE:APN) has been reasonably good and CEO Stephen Saad has done a decent job of steering the company in the right direction. In light of this performance, CEO compensation will probably not…
The main aim of stock picking is to find the market-beating stocks. But the main game is to find enough winners to more than offset the losers So we wouldn't blame long term Aspen Pharmacare Holdings Limited (JSE:APN) shareholders for doub…
There wouldn't be many who think Aspen Pharmacare Holdings Limited's (JSE:APN) price-to-earnings (or "P/E") ratio of 9.9x is worth a mention when the median P/E in South Africa is similar at about 8x. However, investors might be overlookin…
Full Year 2022 Aspen Pharmacare Holdings Ltd Earnings Call Johannesburg Sep 16, 2022 (Thomson StreetEvents) -- Edited Transcript of Aspen Pharmacare Holdings Ltd earnings conference call or presentation Thursday, September 1, 2022 at 6:30:…
(Adds detail) JOHANNESBURG, Aug 31 (Reuters) - Aspen Pharmacare has signed a deal with the Serum Institute of India to manufacture and sell four Aspen-branded vaccines for Africa, as it seeks to utilise its near-idle COVID-19 vaccine produ…
JOHANNESBURG (Reuters) -Aspen Pharmacare has signed a deal with the Serum Institute of India to manufacture and sell four Aspen-branded vaccines for Africa, as it seeks to utilise its near-idle COVID-19 vaccine production lines in eastern…
(Recasts with quotes from Africa CDC) JOHANNESBURG, Aug 11 (Reuters) - Africa's top public health body said on Thursday it was hopeful South African pharmaceutical firm Aspen Pharmacare would get orders for its own brand COVID-19 vaccine.…
* Still no orders for Aspen's own COVID vaccine * Company cannot maintain idle production lines indefinitely (Updates with J&J and additional Aspen executive comment) By Promit Mukherjee and Wendell Roelf JOHANNESBURG, Aug 10 (Reuters) - S…
* Production lines will go idle from month's end, exec says * Still no orders for Aspen's own COVID vaccine * Company cannot maintain idle lines indefinitely By Promit Mukherjee and Wendell Roelf JOHANNESBURG, Aug 10 (Reuters) - South Afri…
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Aspen Pharmacare APNHY is a specialty, branded, and generic pharmaceutical company for acute and chronic conditions.The Zacks Consensus Estimate for its current yea…
* South Africa's Aspen facing poor demand for shots * Could slash production without orders * WHO, Gavi say supplies for COVAX initiative already secured (Adds Kenya details in paras 15, 16) By Promit Mukherjee and Jennifer Rigby JOHANNESB…